Revenue
attach_money3M USD
YoY -92.8%
RNACCartesian Therapeutics, Inc.$ --
Cartesian Therapeutics, Inc.
RNAC
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart-87M USD
YoY -97.5%
Net Income
verified-130M USD
YoY -68.3%
EPS
pie_chart-5.02USD
YoY -67.9%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress205.7%On Track
Revenue Progress2.8M
Revenue Forecast2M
Net Income Progress-130.3M
Net Income Forecast-63.3M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.